CLINICAL STUDIES
Renal circulatory effects of adenosine in patients with chronic heart failure
Uri Elkayam, MD, FACCa,
Anilkumar Mehra, MDa,
Gregory Cohen, MDa,
Padmini Priya Tummala, MDa,
Ilyas Somer Karaalp, MDa,
Omar Rashid Wani, MDa and
Menahem Canetti, MDa
a Division of Cardiology, Department of Medicine, University of Southern California School of Medicine, Los Angeles, California, USA
Manuscript received October 27, 1997;
revised manuscript received March 17, 1998,
accepted March 18, 1998.
Address for correspondence: Dr. Uri Elkayam, University of Southern California School of Medicine, Division of Cardiology, 2025 Zonal Avenue, Los Angeles, California 90033 elkayam{at}hsc.usc.edu
Objectives. We sought to study the renal circulatory effects of adenosine in patients with chronic congestive heart failure (CHF).
Background. Renal blood flow (RBF) is often reduced in patients with chronic CHF and may lead to decreased renal function. The cause of reduced RBF is multifactorial and involves systemic as well as local vasoregulatory mechanisms. Stimulation of renal adenosine A1 receptors in animal models has resulted in a significant vasoconstriction of afferent and efferent glomerular arterioles and deterioration of renal function. Although adenosine serum levels have been shown to be elevated in patients with CHF, their effect on the renal circulation in this patient population has not been studied.
Methods. Nine patients with CHF from left ventricular systolic dysfunction were studied. The effects of adenosine at a dose of 105 mol/liter infused directly into the main renal artery on heart rate, renal artery blood pressure, renal artery cross-sectional area (measured by intravascular ultrasound), renal Doppler blood flow velocity (measured by a Doppler flow wire in the renal artery), RBF and renal vascular resistance (RVR) were evaluated.
Results. Infusion of adenosine resulted in no significant effect on heart rate or renal artery blood pressure but caused a substantial increase in RVR (11,204 ± 1,469 to 31,494 ± 3,911 dynes·s·cm5, p = 0.0005), which led to a marked fall in RBF in every patient (mean values 376 ± 36 to 146 ± 22 ml/m2, p = 0.0002). These changes in RVR and RBF were associated with no significant change in renal artery cross-sectional area (0.389 ± 0.040 to 0.375 ± 0.033 cm2, p = 0.3).
Conclusions. Stimulation of renal adenosine receptors in patients with CHF results in marked renal vasoconstriction that leads to an important reduction in RBF. Lack of change in renal artery cross-sectional area suggests that adenosine affects intrarenal resistance blood vessels rather than large conductance vessels. These results may indicate a rationale for investigation of renal adenosine receptor blockade for enhancement of RBF and improvement of renal function in patients with chronic CHF.
|
Abbreviations and Acronyms
| | ACE | = angiotensin-converting enzyme | | AMP | = adenosine monophosphate | | CHF | = congestive heart failure | | LV | = left ventricular | | RBF | = renal blood flow | | RVR | = renal vascular resistance |
|
This article has been cited by other articles:

|
 |

|
 |
 
U. Elkayam, M. W. Akhter, M. Liu, P. Hatamizadeh, and M. N. Barakat
Assessment of renal hemodynamic effects of nesiritide in patients with heart failure using intravascular Doppler and quantitative angiography.
J. Am. Coll. Cardiol. Img.,
November 1, 2008;
1(6):
765 - 771.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Elkayam, T. M.H. Ng, P. Hatamizadeh, M. Janmohamed, and A. Mehra
Renal Vasodilatory Action of Dopamine in Patients With Heart Failure: Magnitude of Effect and Site of Action
Circulation,
January 15, 2008;
117(2):
200 - 205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. L. P. Stein, B. Schmidt, E. B. Furlong, L. A. S. Soares, M. C. F. Soares, M. R. C. Vaz, and A. L. M. Baisch
Vascular Responses to Extractable Fractions of Ilex paraguariensis in Rats Fed Standard and High-Cholesterol Diets
Biol Res Nurs,
October 1, 2005;
7(2):
146 - 156.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Krier, E. L. Ritman, Z. Bajzer, J. C. Romero, A. Lerman, and L. O. Lerman
Noninvasive measurement of concurrent single-kidney perfusion, glomerular filtration, and tubular function
Am J Physiol Renal Physiol,
October 1, 2001;
281(4):
F630 - F638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. O. Lerman and M. Rodriguez-Porcel
Functional Assessment of the Circulation of the Single Kidney
Hypertension,
September 1, 2001;
38(3):
625 - 629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Gottlieb, S. L. Skettino, A. Wolff, E. Beckman, M. L. Fisher, R. Freudenberger, T. Gladwell, J. Marshall, M. Cines, D. Bennett, et al.
Effects of BG9719 (CVT-124), an A1-Adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure
J. Am. Coll. Cardiol.,
January 1, 2000;
35(1):
56 - 59.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|